FDA of­fi­cials, drug de­vel­op­ers dis­cuss how to stream­line safe­ty mon­i­tor­ing for bi­o­log­ics

FDA of­fi­cials, aca­d­e­m­ic re­searchers and drug de­vel­op­ers gath­ered at the FDA’s head­quar­ters on Mon­day to dis­cuss the land­scape for mon­i­tor­ing the safe­ty and ef­fi­ca­cy of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER